Stellant Securities board meet 2026: ₹17 cr cap plan

Key development flagged to BSE

Stellant Securities (India) Limited has given prior intimation to the Bombay Stock Exchange about a Board of Directors meeting scheduled for July 24, 2026. The company said the board will consider two capital-related proposals in the meeting. First, it will evaluate a significant increase in authorised share capital. Second, it will consider raising funds through a preferential issue of securities, including fixing the issue price.

The update matters because these steps can change the company’s capital structure and potentially set up a new round of issuance. Any preferential issue typically needs regulatory and shareholder approvals, and the pricing decision often becomes a key data point for investors tracking dilution risk. The company also announced a trading window closure under insider trading rules ahead of the meeting.

What the board meeting will cover on July 24, 2026

The company’s intimation to the exchange lists two agenda items. The first is a proposal to increase authorised share capital and amend the capital clause in the Memorandum of Association to reflect the revised limit. The second is a proposal to raise funds via a preferential issue, with the board expected to determine the issue price.

The company added that the board may also transact “other incidental and ancillary matters” connected to the proposals, subject to the Chair’s permission. Such language is common in corporate meeting notices and allows the board to take procedural decisions linked to the main items. But the core decisions remain the authorised capital proposal and the preferential issue plan.

Agenda 1: Proposed authorised share capital increase

Stellant Securities (India) said it will consider increasing its authorised share capital from ₹7,00,00,000 to ₹17,00,00,000. The current authorised capital is divided into 70,00,000 equity shares of ₹10 each. The proposed authorised capital would be divided into 1,70,00,000 equity shares of ₹10 each.

The company described the proposed hike as a 142.86% increase in authorised capital. If approved, the increase would require a consequent amendment to the Capital Clause V of the company’s Memorandum of Association. Authorised capital is the legal ceiling up to which a company can issue shares, and companies typically raise this limit when they expect to issue more equity or equity-linked instruments.

Agenda 2: Fund raising via preferential issue

The second agenda item is a proposal for fund raising through a preferential issue of securities. The company said the board will consider the determination of issue price for the preferential issue. It also clarified that the fund raise will be subject to required regulatory and statutory approvals.

The company specifically noted that shareholder approval will be required. Preferential issues in India are governed by SEBI regulations, stock exchange rules, and the Companies Act process for shareholder consent. The board’s July 24 meeting, as described, is positioned as an initial decision point on structure and pricing before the approvals workflow.

Trading window closure under SEBI insider trading rules

Alongside the board meeting intimation, Stellant Securities (India) announced a trading window closure pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015. The company said the trading window for dealing in its shares will be closed for all Designated Persons and their immediate relatives.

The closure period is from July 21, 2026 until 48 hours after the conclusion of the board meeting considering the agenda items. Trading window closures are typically applied around the time of unpublished price sensitive information such as fundraising decisions, capital changes, or financial results. The timeline disclosed by the company is meant to align internal dealing restrictions with the expected decision date.

Background: the company’s earlier capital actions (2025)

In earlier disclosures cited in the provided material, the company had discussed similar capital and preferential issue actions. A board meeting on November 14, 2025 considered and approved, subject to shareholder approval, an increase in authorised share capital from ₹5,00,00,000 to ₹7,00,00,000, with a corresponding change in the Memorandum of Association.

The same November 2025 corporate update also referenced a preferential issue proposal involving convertible warrants and equity shares. The figures included 7,05,882 warrants at an issue price of ₹340 per warrant aggregating to ₹23,99,99,880, and 25,57,730 equity shares at an issue price of ₹290 per share aggregating to ₹74,17,41,700. Together, those two legs summed to ₹98.17 crore as stated in the provided material.

Background: approvals and allotment decisions (December 2025 to February 2026)

The provided material also notes that shareholder consent for the capital-raising exercise was secured at an Extraordinary General Meeting held on December 10, 2025. It further mentions that in-principle approval from BSE Ltd was obtained on January 19, 2026 for the corporate action.

At a Board meeting held on February 2, 2026, Stellant Securities (India) approved the allotment of 18,33,595 equity shares at an issue price of ₹290 per share, including a premium of ₹280 per share. The board also approved 3,00,000 warrants at an issue price of ₹340 per warrant, convertible into equity shares of ₹10 face value, including a premium of ₹330 per warrant. Separately, the material states that promoters Subhash Phootarmal Rathod and Mangala Subhash Rathod acquired 3 lakh fully convertible warrants through preferential allotment, increasing their total effective diluted shareholding by 5.14% to 46.65% on February 02, 2026.

What the July 2026 proposals could mean for investors

If the board approves the authorised capital increase from ₹7 crore to ₹17 crore, it would expand the company’s headroom to issue additional equity shares. This step does not itself dilute shareholders, but it can be a precursor to future issuance, including preferential allotments. The proposed preferential issue agenda, especially the determination of the issue price, is typically the operational trigger investors watch because it can influence the implied valuation and potential dilution.

The company has also clearly signalled that the fundraising plan will be subject to approvals, including shareholder consent. That means investors should expect additional disclosures if the board decides to proceed, such as details of the proposed securities, identified allottees if any, pricing rationale, and timelines for shareholder meetings. The trading window closure indicates the company considers these deliberations potentially price sensitive under SEBI’s insider trading framework.

Summary table: key facts disclosed by the company

Conclusion

Stellant Securities (India) has put capital structure actions back on the agenda with a July 24, 2026 board meeting to consider a ₹7 crore to ₹17 crore authorised capital increase and a preferential issue proposal. The company has also implemented a trading window closure from July 21, 2026 in line with SEBI insider trading rules.

The next concrete checkpoint for investors will be the outcome of the board meeting, particularly whether the board approves the proposals and whether the company initiates the shareholder and regulatory approval process for any preferential issue.